📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
0 analysed today
FollowTelegram
0
Today
152,139
All-time analysed
43,645
Positive
6,747
Negative
92,898
Neutral
8,781
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
520 announcements match the current filters (relevance ≥ 5).
CARE Ratings Subsidiary Receives ESG Rating License from IFSCA
CARE Ratings' wholly-owned subsidiary, CareEdge Global IFSC Limited, has successfully obtained a license from the International Financial Services Centres Authority (IFSCA) on March 11, 2026. This license permits the subsidiary to operate as an ESG Rating and Data Product Provider within the International Financial Services Centre. This strategic move allows the company to enter the rapidly growing global market for Environmental, Social, and Governance (ESG) assessments. The expansion diversifies the company's revenue streams beyond traditional credit rating services.
Key Highlights
Wholly-owned subsidiary CareEdge Global IFSC Limited received the IFSCA license on March 11, 2026.
Authorized to function as an ESG Rating and Data Product Provider in the IFSC.
Positions CARE Ratings to capture demand in the specialized global ESG services market.
The license represents a regulatory milestone for the company's international service offerings.
👀 What to Watch
Investors should view this as a positive long-term growth driver that diversifies the company's portfolio. Monitor the scale of operations and revenue contribution from this new ESG vertical in future earnings reports.
Waaree Renewable Bags Major 300 MWac/420 MWp Solar EPC Order
Waaree Renewable Technologies Limited (WAAREERTL) has signed a contract for the Engineering, Procurement, and Construction (EPC) of a 300 MWac / 420 MWp Ground Mount Solar PV Plant. The order was awarded by a domestic renewable energy power generation company and is scheduled for completion in FY 2027-28. This significant win bolsters the company's project pipeline and ensures medium-term revenue visibility. The contract is a commercial order with no promoter interest or related party involvement.
Key Highlights
Signed EPC contract for a 300 MWac (420 MWp) Ground Mount Solar PV Plant
Project execution is scheduled for completion during the financial year 2027-28
Awarded by a domestic entity specializing in renewable energy power generation
The contract is a commercial order and is not a related party transaction
👀 What to Watch
Investors should view this as a positive development for the order book, providing revenue visibility through FY28. Monitor the company's execution efficiency and margin management as it scales its project portfolio.
Waaree Energies Subsidiary to Invest $30 Million in United Solar Holdings Inc.
Waaree Energies' wholly owned subsidiary, Waaree Solar Americas Inc., has signed a Share Subscription Agreement to invest approximately $30 million in United Solar Holdings Inc. (USH). The deal involves the acquisition of 5,368,551 Series B preferred shares of USH, marking a significant strategic move in the American market. This transaction follows a preliminary disclosure made in December 2025 and is subject to standard closing conditions. The investment is an arm's length transaction with no related party involvement.
Key Highlights
Investment of approximately USD $30 million in United Solar Holdings Inc.
Subscription of 5,368,551 Series B preferred shares through US subsidiary Waaree Solar Americas Inc.
Strategic follow-up to the company's previous disclosure dated December 19, 2025.
Transaction is not a related party deal and involves no promoter interest.
👀 What to Watch
Investors should view this as a positive step toward deepening the company's footprint in the US solar sector. Monitor for further updates on the closing of the transaction and potential operational synergies.
Hindware Home Innovation Convenes NCLT Meetings for Composite Scheme of Arrangement
Hindware Home Innovation Limited held NCLT-convened meetings on March 7, 2026, to seek approval for a Composite Scheme of Arrangement involving the company, HHIL Limited, and Hindware Limited. The meetings included equity shareholders and unsecured creditors of both the parent company and its subsidiary, Hindware Limited. Voting was conducted via polling papers based on a cut-off date of September 30, 2025. The final results of the voting are expected to be declared within seven days following the submission of the scrutinizer's report.
Key Highlights
NCLT-convened meetings held on March 7, 2026, for shareholders and unsecured creditors.
Proposed Composite Scheme of Arrangement involves Hindware Home Innovation, HHIL Ltd, and Hindware Ltd.
Voting eligibility for all participants was determined based on a cut-off date of September 30, 2025.
Final voting results and the Scrutinizer's report are to be declared within 7 days of the meeting conclusion.
👀 What to Watch
Investors should monitor the upcoming announcement of the voting results to confirm if the restructuring scheme has been approved by the required majority. It is important to review the specific terms of the arrangement to understand the long-term impact on share value.
Share India Appoints Former CBDT Chairman Arun Kumar Jain as Independent Director
Share India Securities has appointed Mr. Arun Kumar Jain as an Additional Non-Executive Independent Director for a five-year term effective March 05, 2026. Mr. Jain is a highly distinguished professional, having served as the Chairman of the Central Board of Direct Taxes (CBDT) and holding an extensive background in the Indian Revenue Service. The appointment has received necessary approvals from major exchanges including NSE, BSE, MCX, MSEI, and NCDEX. This strategic addition is expected to significantly bolster the company's governance and regulatory compliance framework.
Key Highlights
Appointment of Mr. Arun Kumar Jain as Non-Executive Independent Director for a 5-year term until March 04, 2031.
Mr. Jain is a former Chairman of the Central Board of Direct Taxes (CBDT) with expertise in taxation and finance.
Final regulatory approvals from NSE, BSE, MCX, MSEI, and NCDEX were received on March 05, 2026.
Shareholder approval for the appointment will be sought within the next three months.
👀 What to Watch
Investors should view this as a positive development for the company's corporate governance and regulatory standing. No immediate portfolio action is required based on this appointment.
Religare Subsidiary Care Health Insurance Receives IRDAI Show Cause Notice
Religare Enterprises Limited's material subsidiary, Care Health Insurance Limited (CHIL), has received a Show Cause Notice (SCN) from IRDAI dated March 02, 2026. The notice follows a thematic onsite inspection conducted in February 2025 and alleges violations of multiple regulatory frameworks, including policyholder interest and actuarial functions. While the company currently reports no material financial impact, any future penalties will be consolidated into Religare's financial statements. CHIL is in the process of filing a response and taking remedial actions as advised by the regulator.
Key Highlights
IRDAI issued a Show Cause Notice to material subsidiary Care Health Insurance on March 02, 2026.
The notice is based on a thematic onsite inspection conducted from February 10 to February 14, 2025.
Alleged violations involve Master Circulars on Operations, Policyholder Interests, and Health Insurance Business (2024).
Management states there is no immediate material impact on financials or operations of the listed entity.
CHIL is preparing a formal reply and implementing remedial steps to address IRDAI observations.
👀 What to Watch
Investors should monitor the final adjudication of this notice as any significant penalty or operational restriction on the insurance subsidiary could affect Religare's consolidated valuation. Maintain a watch on the regulatory compliance status of Care Health Insurance.
Waaree Energies Clarifies 126% US Duty Impact; Reaffirms Guidance and US Expansion
Waaree Energies clarified that the preliminary 126% US countervailing duty on Indian solar imports does not apply to its products as it sources cells from non-Indian jurisdictions with lower 10-15% tariff rates. The company is aggressively expanding its US manufacturing capacity from 2.6 GW to 4.2 GW by the end of 2026 to further mitigate trade risks. Management reaffirmed its financial guidance and stated that the US order book remains unaffected by these regulatory developments. The company's diversified supply chain, including investments in Oman, provides a strategic buffer against shifting global trade policies.
Key Highlights
Preliminary US CVD of 126% is not applicable to Waaree as it avoids using India-made cells for US exports.
US manufacturing capacity is set to reach 4.2 GW by year-end 2026, up from the current 2.6 GW.
Cell sourcing is currently tied to jurisdictions with 10-15% tariffs, significantly lower than the new 126% rate.
Management reaffirmed annual guidance and confirmed no material impact on US order book margins.
Strategic investment in Oman and non-China supply chains since 2019 ensures full traceability for US compliance.
👀 What to Watch
Investors should find confidence in Waaree's proactive supply chain diversification and US-based manufacturing strategy which shields it from high tariffs. Monitor the timely execution of the 4.2 GW US capacity expansion as a key growth driver.
Waaree Energies Schedules Urgent Call to Discuss U.S. Duties on Indian Solar Imports
Waaree Energies Limited convened an urgent conference call on February 25, 2026, to address recent news regarding U.S. duties on Indian solar imports. The call featured top management, including the CEO and CFO, to provide clarity on how these trade developments might affect the company's operations. This meeting was organized at short notice in compliance with specific SEBI disclosure circulars. Investors are closely monitoring the situation as the U.S. is a critical market for Indian solar manufacturers.
Key Highlights
Conference call held on February 25, 2026, at 1:30 PM IST specifically to discuss U.S. solar import duties.
Top leadership participation including CEO Amit Paithankar and CFO Sonal Shrivastava.
Call initiated at short notice under SEBI Circular SEBI/HO/CFD/CFD-PoD-2/P/CIR/2025/25.
Discussion focused on the implications of international trade policy on the company's export business.
👀 What to Watch
Investors should review the audio recording or transcript of the call to assess the potential impact on export margins and the company's U.S. order book. Maintain a watch on the stock as clarity emerges regarding the severity of the U.S. tariffs.
Share India Securities Activated as NSDL Depository Participant Effective Feb 24, 2026
Share India Securities Limited has officially been activated as a Depository Participant (DP) with the National Securities Depository Limited (NSDL) as of February 24, 2026. This activation allows the company to expand its suite of financial services by offering NSDL depository services in addition to its existing CDSL membership. The company received official confirmation from NSDL on the evening of February 24, 2026, and subsequently informed the exchanges. This move is expected to strengthen the company's position in the broking and depository segment by providing more options to its clients.
Key Highlights
Official activation as an NSDL Depository Participant effective February 24, 2026
Expansion of service offerings to include NSDL depository services alongside existing CDSL services
Compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
The company maintains memberships with NSE, BSE, MCX, NCDEX, and MSEI
Intimation received from NSDL at 07:43 p.m. on February 24, 2026
👀 What to Watch
Investors should monitor the company's ability to scale its depository participant business and its impact on non-brokerage fee income. This operational milestone enhances the company's competitive standing in the full-service brokerage space.
Waaree Energies Calls Urgent Investor Meet on U.S. Solar Import Duties
Waaree Energies Limited has convened an emergency analyst call on February 25, 2026, to address recent news concerning U.S. duties on Indian solar imports. The meeting, scheduled for 1:30 PM IST, involves top leadership including the CEO and CFO to provide clarity on trade developments. This urgent disclosure follows specific SEBI guidelines for rapid investor communication on material events. The outcome is critical as the U.S. is a major market for Indian solar module manufacturers.
Key Highlights
Conference call scheduled for February 25, 2026, at 1:30 PM IST on short notice.
Focus on clarifying the impact of new U.S. import duties on Indian solar products.
Participation from CEO Amit Paithankar and CFO Sonal Shrivastava.
Compliant with SEBI circular dated February 25, 2025, regarding shorter notice periods.
👀 What to Watch
Closely track the management's commentary regarding the potential impact on export margins and order books. The stock may experience volatility until the financial implications of the U.S. duties are quantified.
Waaree Energies Clarifies on US Solar Tariffs; Confirms No Undisclosed Price Sensitive Info
Waaree Energies has addressed stock exchange queries regarding news of US solar tariffs which led to a 5-10% decline in its stock price on February 25, 2026. The company stated that the preliminary countervailing duties imposed by the U.S. Department of Commerce are industry-wide regulatory measures affecting the entire solar sector. It confirmed that there is no unpublished price sensitive information (UPSI) and that the recent price movement is entirely market-driven. No legal or regulatory proceedings have been initiated against the company in this context.
Key Highlights
Responded to BSE/NSE clarification requests regarding news of US tariff impacts on solar stocks
Noted that the stock had trimmed losses after falling 5-10% following the tariff news
Confirmed that the U.S. Department of Commerce's tariff measures are industry-wide and not company-specific
Asserted full compliance with SEBI Regulation 30 and confirmed no pending UPSI
👀 What to Watch
Investors should monitor the final duty rates from the US Department of Commerce as they will impact export competitiveness. The stock remains sensitive to US trade policy changes given its significant export focus.
Waaree Energies Responds to 126% U.S. Import Duty; Targets 4.2 GW U.S. Capacity by FY27
Waaree Energies is addressing the U.S. Department of Commerce's preliminary 126% countervailing duty on Indian solar imports, a sharp rise from previous levels. To mitigate this, the company is leveraging its current 2.6 GW U.S. manufacturing capacity and plans to expand it to 4.2 GW by FY27. Additionally, it is diversifying its supply chain with investments in Oman for non-Chinese polysilicon to ensure compliance and resilience. Management believes these localized production efforts will allow them to fulfill U.S. orders without material adverse impacts.
Key Highlights
U.S. Dept of Commerce imposed preliminary 126% countervailing duties on Indian solar imports.
Waaree currently operates 2.6 GW of U.S. module manufacturing capacity, including the Meyer Burger facility.
Expansion plan to reach 4.2 GW U.S. capacity by the end of FY27 is currently underway.
Strategic investments in Oman for non-Chinese polysilicon to ensure supply chain traceability and resilience.
Management expects no material impact on servicing the U.S. order book due to localized manufacturing hedge.
👀 What to Watch
Investors should closely monitor the final duty determination and the execution speed of the U.S. capacity expansion to 4.2 GW. The company's ability to shift production to its U.S. facilities is a critical buffer against these high import tariffs.
Waaree Energies Calls Urgent Investor Meet to Discuss U.S. Solar Import Duties
Waaree Energies Limited has scheduled an urgent conference call on February 25, 2026, at 1:30 PM IST to address recent developments regarding U.S. duties on Indian solar imports. The meeting is being held on short notice, highlighting the potential significance of these trade policy changes on the company's export business. Senior management, including the CEO and CFO, will participate to clarify the impact of international trade regulations on operations. This call is critical as the U.S. market is a major revenue driver for Indian solar manufacturers.
Key Highlights
Conference call scheduled for February 25, 2026, at 1:30 PM IST on short notice.
Agenda focused specifically on the impact of U.S. duties on Indian solar imports.
Top management participation including CEO Amit Paithankar and CFO Sonal Shrivastava.
Meeting follows SEBI circular SEBI/HO/CFD/CFD-PoD-2/P/CIR/2025/25 regarding timely disclosures.
👀 What to Watch
Investors should monitor the call outcomes closely to understand potential impacts on export margins and order book execution. Await management's strategy on mitigating trade barriers before making significant portfolio adjustments.
Thyrocare Infuses Additional USD 475,000 in Tanzania Subsidiary via CCPS
Thyrocare Technologies has invested an additional USD 475,000 (approx. INR 4.33 Crores) into its subsidiary, Thyrocare Laboratories (Tanzania) Limited. This capital infusion was executed through Compulsorily Convertible Irredeemable Preference Shares (CCPS) to support working capital and business operations. The total investment in the Tanzanian venture now reaches approximately INR 10.02 Crores, against a board-approved limit of INR 15 Crores. While the subsidiary is scaling with a turnover of INR 1.84 Crores in 2025, it currently reports a negative net worth of INR 0.32 Crores.
Key Highlights
Additional investment of USD 475,000 (INR 4.33 Crores) via subscription to CCPS.
Total cumulative investment in the Tanzanian subsidiary now stands at INR 10.02 Crores.
Thyrocare Tanzania reported a turnover of INR 1.84 Crores for the year ended December 31, 2025.
The company maintains a 57.25% equity stake and 100% CCPS holding in the joint venture.
Board approval allows for a total investment of up to INR 15 Crores in one or more tranches.
👀 What to Watch
Investors should monitor the turnaround and scaling of the Tanzanian operations, as the subsidiary currently has a negative net worth. While the investment amount is small relative to Thyrocare's balance sheet, it reflects the company's commitment to international expansion.
Waaree Energies Subsidiary Secures 300MW Wind Power Project from SECI
Waaree Energies' wholly-owned subsidiary, Waaree Forever Energies Private Limited, has received a Letter of Award from the Solar Energy Corporation of India (SECI). The contract involves the development of a 300MW Wind Power Project located in Dwarka, Gujarat. This project includes a Power Purchase Agreement (PPA) that will be valid for a long-term duration of 25 years from the commencement of supply. This win signifies the company's successful expansion into the wind energy segment alongside its established solar business.
Key Highlights
Awarded a 300MW Wind Power Project in Dwarka, Gujarat by SECI
Secured a long-term Power Purchase Agreement (PPA) valid for 25 years
Project to be executed via wholly-owned subsidiary Waaree Forever Energies Private Limited
Strengthens the company's renewable energy portfolio beyond solar manufacturing
👀 What to Watch
Investors should view this as a positive development for long-term revenue visibility and business diversification. Monitor the company's execution progress and any upcoming capital expenditure plans related to this wind project.
Waaree Energies Bags 500MW Solar Module Supply Order for FY 2026-27
Waaree Energies Limited has secured a significant domestic order for the supply of 500MW solar modules. The contract was awarded by a prominent solar power developer and Independent Power Producer (IPP) in India. The supply is scheduled to be executed during the 2026-27 financial year, providing strong revenue visibility for the company. This order underscores Waaree's competitive position in the domestic solar manufacturing market.
Key Highlights
Secured a major order for the supply of 500MW solar modules to a domestic entity.
The customer is a renowned solar power developer and Independent Power Producer (IPP).
The entire supply of modules is scheduled for completion within the FY 2026-27 period.
The contract is a one-time supply agreement and is not a related party transaction.
👀 What to Watch
This order provides clear revenue visibility for the next fiscal year; investors should remain positive while monitoring the company's execution efficiency and margin protection.
Share India to Invest ₹6 Crore in Subsidiary Share India Cred Capital via Rights Issue
Share India Securities has approved an additional investment of ₹5.99 crore in its subsidiary, Share India Cred Capital Private Limited (SICCPL). The company will acquire 59,93,994 equity shares at a face value of ₹10 each through a rights issue. SICCPL is a newly incorporated entity (January 2026) that will focus on structured credit, debt syndication, and pre-IPO equity deals. This capital infusion is aimed at strengthening the subsidiary's capital base to support its initial operations and expansion.
Key Highlights
Acquisition of 59,93,994 equity shares at a face value of ₹10 per share for a total of ₹5.99 crore.
Share India Securities will maintain its 60% majority stake in SICCPL following the rights issue subscription.
Target entity SICCPL was recently incorporated on January 6, 2026, and operates in the financial services industry.
The investment is expected to be completed within 5 working days from the disclosure date.
SICCPL will focus on high-growth areas like debt syndication, structured credit, and trading in unlisted/pre-IPO securities.
👀 What to Watch
Investors should view this as a routine capital allocation to a new business vertical; monitor the subsidiary's performance in upcoming quarters to see its impact on consolidated margins. No immediate portfolio changes are recommended based on this modest investment size.
Waaree Energies Signs 2.5 MW EAAS Agreement and 50 MW Strategic MoU for Green Hydrogen
Waaree Energies' subsidiary has entered a 15-year Electrolyzer as a Service (EAAS) agreement with Zero Footprint Industries (ZFI) for a 2.5 MW project in Uttar Pradesh. The partnership also includes a strategic MoU to supply 50 MW of electrolyzers for decentralized green hydrogen projects across Northern India. The initial project aims to produce 41 lakh Nm3 of green hydrogen annually, with commercial operations slated for Q3 FY 2026-27. This move establishes Waaree as a key player in the green hydrogen infrastructure and services market.
Key Highlights
Signed a 15-year long-term contract for a 2.5 MW alkaline electrolyzer project in Uttar Pradesh
Strategic MoU for 50 MW of electrolyzer supply via the Electrolyzer as a Service (EAAS) model
Initial project targets annual production of 41 lakh Nm3 of green hydrogen and 20 lakh Nm3 of green oxygen
Fast-track execution with commercial operations expected by Q3 FY 2026-27
Potential to scale capacity to 10,000 m3/hr across multiple locations over the next five years
👀 What to Watch
This deal validates Waaree's technology in the green hydrogen space and introduces a recurring revenue model through EAAS. Investors should monitor the timely commissioning of the first project as a benchmark for the larger 50 MW MoU.
Religare Enterprises Q3 FY26 Income Rises to ₹2,067.9 Cr; Care Health AUM Crosses ₹10,000 Cr
Religare Enterprises reported a consolidated total income of ₹2,067.9 crores for Q3 FY26, up from ₹1,670.2 crores in the same quarter last year. Despite revenue growth, the company posted a consolidated loss before tax of ₹103.1 crores, impacted by one-time employee benefit provisions under the new labor code. The insurance subsidiary, Care Health, remains a strong performer with retail business growing 41% and its AUM crossing the ₹10,000 crore milestone. Governance remains a focal point with the proposed induction of Burman family members and Jimeet Modi to the Board.
Key Highlights
Consolidated total income increased to ₹2,067.9 crores in Q3 FY26 vs ₹1,670.2 crores in Q3 FY25.
Care Health Insurance retail premium grew by 41% YoY, with total 9M premium reaching ₹7,906 crores.
Care Health AUM crossed ₹10,000 crores with a solvency ratio of 1.70 as of December 2025.
One-time wage code provisions of ₹13.5 crores impacted quarterly profitability in the insurance segment.
Board expansion proposed to include Dr. Anand Burman, Mohit Burman, Aditya Chand Burman, and Jimeet Modi.
👀 What to Watch
Investors should monitor the transition in board leadership and the impact of the new management team on long-term strategy. While the consolidated loss is a concern, the robust growth and market share gains in the health insurance subsidiary provide a strong underlying valuation support.
Saregama Incorporates Wholly Owned Subsidiary in Dubai with AED 1 Million Capital
Saregama India Limited has successfully incorporated a new wholly owned subsidiary in Dubai, UAE, named 'Saregama Performing Arts and Music Festivals L.L.C S.O.C'. The entity is established with a share capital of AED 1,000,000, consisting of 1,000 shares at AED 1,000 each. This move aims to expand the company's footprint in the digital entertainment and live events space, specifically focusing on music festivals, artist talent contracting, and theatrical productions. The incorporation follows a board approval granted in September 2025, marking a strategic push into the Middle Eastern market.
Key Highlights
Incorporated 'Saregama Performing Arts and Music Festivals L.L.C S.O.C' as a 100% subsidiary in Dubai Mainland
The subsidiary has a total share capital of AED 1,000,000 (approx. INR 2.25 Crores) distributed into 1,000 shares
Business focus includes live events, music festivals, artist contracting, and theatrical show production
The Certificate of Incorporation and Commercial License were issued on February 20, 2026
👀 What to Watch
Investors should monitor the company's execution in the live events and artist management space in the UAE. This diversification into global live entertainment could provide a high-margin revenue stream beyond traditional music licensing.
